Tick saliva-based drug could lower heart disease risk in HIV patients HIV treatments have made enormous strides in recent decades, but patients—even those on antiretroviral drugs—have a higher risk of […]
Stada close to naming pharma veteran Albrecht as new CEO: report Hoping to land on its feet after a tough year and a long-time-coming buyout, Stada is nearly ready to […]
At 5,000, is Novartis’ Kymriah a bargain—or another example of skyrocketing prices? Novartis won its FDA approval for CAR-T drug Kymriah on Wednesday, but questions about pricing, access and more […]
Daiichi axes 0M pain pact 7 months after FDA setback Daiichi Sankyo has cut and run from its $650 million pain alliance with Charleston Laboratories. The decision comes seven months […]
‘Hit-and-run’ gene therapy nanoparticles could enhance CAR-T treatments Personalized cancer treatments known as CAR-T cells have dominated the headlines lately, but they are labor-intensive and expensive to make, and they […]
The Medicines Co. nets 0M nod for UTI antibacterial treatment Doctors treating patients with complicated urinary tract infections will soon have a new tool in their arsenal with the FDA’s […]
Novartis crosses FDA finish line with monumental CAR-T leukemia approval In a historic day for cancer treatment and the larger biopharma industry, Novartis notched an FDA approval for its CAR-T […]
Stealthy Torque powers through with M raise Flagship Pioneering’s quiet oncology upstart Torque Therapeutics has filed a $21 million raise as it lands in Kendall Square. Source: FierceMedicalDevices News Stealthy […]
FDA targets rogue clinic using Sanofi’s smallpox vaccine in unapproved cancer therapy As part of a crackdown on stem cell treatment centers, the FDA seized a controlled smallpox vaccine from […]
Allergan heads to federal court to defend Restasis against early generic rivals In defense of a top seller, Allergan is squaring off against a cadre of generics companies in Texas […]